Search

Search Results

• 

  Update on treatment of polymyalgia rheumatica

  D. Camellino, C. Dejaco

  59-66

  27-03-2018

  Published: 27 March 2018

  5723

  PDF: 3320
• 

  Glucocorticoid-induced osteoporosis: 2013 update

  M. Mazzantini, O. Di Munno

  144-152

  28-07-2014

  Published: 28 July 2014

  3533

  PDF: 2165
• 

  Possible interplay between interleukin-15 and interleukin-17 into the pathogenesis of idiopathic inflammatory myopathies

  A. Notarnicola, G. Lapadula, D. Natuzzi, F. Iannone

  215-223

  06-11-2014

  Published: 6 November 2014

  1673

  PDF: 1144
• 

  The role of the general practitioner and the out-of-hospital public rheumatologist in the diagnosis and follow-up of patients with polymyalgia rheumatica

  A. Sobrero, C. Manzo, A. Stimamiglio

  44-50

  27-03-2018

  Published: 27 March 2018

  2332

  PDF: 1238

• Therapy of rheumatic polymyalgia: the pathophysiologic management

  M. Cutolo, M. Olivieri, M.E. Secchi, M.A. Cimino

  271-279

  Published:

  1441

  PDF: 2054
• 

  Contribution of the new 2012 EULAR/ACR classification criteria for the diagnosis of polymyalgia rheumatica

  F. Muratore, C. Salvarani, P. Macchioni

  18-22

  27-03-2018

  Published: 27 March 2018

  2888

  PDF: 1615
• 

  Perspectives and unmet needs in polymyalgia rheumatica. Providing the fundamental framework for the development of new treatment regimes in polymyalgia rheumatica

  B.D. Nielsen, B. Dasgupta

  1-9

  27-03-2018

  Published: 27 March 2018

  2104

  PDF: 1539
• 

  Prevention and treatment of glucocorticoid-induced osteoporosis in International and Italian scenarios

  O. Di Munno, A. Delle Sedie

  67-79

  Published:

  1529

  PDF: 904

• Idiopathic hypereosinophilic syndrome associated with rheumatoid arthritis A case report

  D. Bonanno, R. Fedele, P. Minciullo, P. Quattrocchi, B. Ferlazzo

  181-183

  Published:

  1899
• 

  Prevalence and incidence of osteoporotic fractures in patients on long-term glucocorticoid treatment for rheumatic diseases: the Glucocorticoid Induced OsTeoporosis TOol (GIOTTO) study

  M. Rossini, O. Viapiana, M. Vitiello, N. Malavolta, G. La Montagna, S. Maddali Bongi, O. Di Munno, R. Nuti, C.U. Manzini, C. Ferri, L. Bogliolo, A. Mathieu, F. Cantatore, A. Del Puente, M. Muratore, W. Grassi, B. Frediani, G. Saviola, P. Delvino, L. Mirone, G. Ferraccioli, G. Tripi, I. Piazza, D. Gatti

  30-39

  22-05-2017

  Published: 22 May 2017

  4358

  PDF: 2966
• 

  The Italian Society of Rheumatology clinical practice guidelines for the management of large vessel vasculitis

  N. Ughi, R. Padoan, C. Crotti, S. Sciascia, G. Carrara, A. Zanetti, D. Rozza, S. Monti, D. Camellino, F. Muratore, G. Emmi, L. Quartuccio, S. Morbelli, K. El Aoufy, S. Tonolo, R. Caporali, S. De Vita, C. Salvarani, M.A. Cimmino

  07-02-2022

  Published: 7 February 2022

  9156

  PDF: 1959
• 

  Management of giant cell arteritis among general practitioners from Genoa, Italy: a web-based survey

  P. Clini, A. Stimamiglio , D. Camellino, E. Hysa, M. Cutolo, M.A. Cimmino

  207-212

  18-01-2021

  Published: 18 January 2021

  3074

  PDF: 503

• Patients with anti-small ubiquitin-like modifier activating enzyme-positive dermatomyositis resembling antisynthetase syndrome with poor prognosis: a bicentric international retrospective study and literature review

  Camila Gusmão Vicente de Carvalho, Barbara Bayeh, Fernando Henrique Carlos de Souza, Renata Miossi, Pleiades Tiharu Inaoka, Takashi Matsushita, Naoki Mugii, Samuel Katsuyuki Shinjo

  09-10-2024

  Published: 9 October 2024

  1069

  PDF: 108

• Small molecules in idiopathic inflammatory myopathies: a systematic review and a multicenter case series about Janus kinase inhibitors and apremilast

  Chiara Rizzo, Silvia Grazzini, Edoardo Conticini, Hector Chinoy, Roberto D’Alessandro, Federica Camarda, Luca Cantarini, Bruno Frediani, Giuliana Guggino, Lidia La Barbera

  13-01-2025

  Published: 13 January 2025

  487

  PDF: 184

  SUPPLEMENTARY MATERIAL: 13

• Treatment of spondyloarthritis with disease-modifying anti-rheumatic drugs during pregnancy and breastfeeding: comparing the recommendations and guidelines of the principal societies of rheumatology

  M. Manara, D. Bruno, M. Ferrito, S. Perniola, R.F. Caporali, E. Gremese

  11-09-2024

  Published: 11 September 2024

  1427

  PDF: 740
• 

  Infliximab as successful treatment option in a case of adenosine deaminase 2 deficiency

  M.B. Ates, S. Karup, S. Ugurlu

  19-12-2023

  Published: 19 December 2023

  1142

  PDF: 320

• Glucocorticoid-induced osteoporosis and rheumatic diseases. Pathogenesis, prevention and treatment

  Ombretta Di Munno, Andrea Delle Sedie

  11-21

  Published:

  1101

  PDF: 1489
• 

  Diagnosis and treatment of interstitial lung disease related to systemic autoimmune myopathies: a narrative review

  F.H.C. De Souza, D.B. De Araújo, L.S. Hoff, B.G. Baldi, M.S.M.S. Faria, L.F da Rocha Junior, L.R.S Da Silva, G.L Behrens Pinto, M.C. Bezerra, R. Miossi, R.A. Cordeiro, S.K Shinjo

  08-05-2023

  Published: 8 May 2023

  1868

  PDF: 971

• Relapsing polycondritis associated with microscopic polyangiitis: description of a clinical case

  L. Breviglieri, F. Zizzi, P. Rocchi, G. Frascà, G. D’Arcangelo, C. Rimondi, L. Frizziero

  151-155

  Published:

  904

  PDF: 949

• Baricitinib in polymyalgia rheumatica and giant cell arteritis: report of six cases

  Dario Camellino, Christian Dejaco, Franco Martini, Renzo Cosso, Gerolamo Bianchi

  28-10-2024

  Published: 28 October 2024

  1015

  PDF: 79